Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-app
Short Description: Onc dx rectal t1-3,n1-2noprg
Coverage Code: Carrier judgment
Action Code: No maintenance for this code
Date Added: January 1, 2006
Effective Date: January 1, 2007
Termination Date: